Anesthesia CO2 absorbents refer to medical grade chemicals. They are used in closed breathing environments to remove carbon dioxide (CO2) from breathing gases. CO2 absorbent is proposed for use in anesthesia circle systems for the purpose of removing respired carbon dioxide. The absorption of CO2 is mandatory in closed & semi-closed circle breathing systems. The elimination of CO2 from exhaled gases is accomplished through chemical neutralization in transparent containers containing absorbent granules. The ideal CO2 absorbent have low airflow resistance, high efficiency, no toxicity or reactions with inhalation anesthetics, and low cost. Effective Co2 absorption prevents CO2 rebreathing & development of hypercapnia.
According to study, “World Anesthesia CO2 Absorbent Market Research Report 2024(Covering USA, Europe, China, Japan, SEA and India)” the key companies operating in the world anesthesia CO2 absorbent market are CareFusion (Becton Dickinson and Co.), Allied Healthcare Products, Drager Medical GmbH, Micropore, Armstrong Medical, Thomasnet, Intersurgical, King Pharmaceuticals, Molecular Products, Smiths Medical, GE Healthcare, SCL International, Medisize. In order to improve market position, the key companies are focusing on adopting the strategies for instance product innovations, recent developments, mergers & acquisitions, joint venture, collaborations, and partnership.
Based on type, anesthesia CO2 absorbent market is segmented into premium anesthesia CO2 absorbent and traditional anesthesia CO2 absorbent. Based on product type, market is segmented into medisorb, sodalime, amsorb, dragersorb, litholyme and others. Amsorb is estimated to witness the fastest growth over the forecast period due to rise in demand for absorbents free from presence of KOH and simplicity in exhaustion indication. Based on form, market is segmented into powered form (bounded by polymer) and granular form. In addition, based on end-use, market is segmented into clinics and hospitals.
The anesthesia CO2 absorbent market is driven by growth in the number of people undergoing surgical procedures, followed by increase in presence of well-developed healthcare sector, rise in supportive government initiatives, increase in number of surgeries, surge in occurrence of accidents & chronic ailments (neurological conditions, respiratory disorders, cardiac arrest, and diabetes), increase in usage of regional anesthesia, and rise in percentage of geriatric population. However, stringent government regulations and medical safety concerns related to an improper administration of anesthesia may impact the market. Moreover, worldwide guidelines & safety parameters pertaining the use of anesthesia and increase in investment on developing newer CO2 absorbing formulations are key opportunities for market.
The Anesthesia Patient Safety Foundation and Centers for Disease Control and Prevention (CDC) are government institutes which provide a better understanding of inevitable anesthetic injuries, encourage programs that will decrease the number of anesthetic injuries, and promote national & international communication of information or ideas about the causes & prevention of anesthetic injuries.
Based on geography, USA country holds major share, followed by Europe in anesthesia CO2 absorbent market owing to escalation in the number of surgeries being performed, endeavors of healthcare agencies to promote medical tourism and favorable government regulations in the country. China, India and Japan countries are expected to witness higher growth rate due to considerable increase in per capita health expenditure and rapid development of healthcare sector over the forecast period. The market will register 8.2% CAGR in terms of proceeds, the global market size will reach US $82 million by 2024, from US $51 million in 2019.
For more information, refer to below link:-
Ankur Gupta, Head Marketing & Communications